Hair loss solutions and remedies - Hair clone
Protocol of the test
So far, no authorization for widespread use of the treatment on humans has been released by the relevant authorities responsible for the public health (FDA or MHRA). In 2005, Intercitex made some tests called ICX-TRC on 7 patients in England. An area of 1 cm2 has received 100 injections of stem cells theoretically capable to produce 100 hairs. The results announced are quite nebulous. Is this for the sake of discretion or because the results are not enough conclusive? It is just "increasing the number of hair" on 5 out of 7 patients. No precise presentation, documented by pictures and by hair-counting has been made public. Dr. Kemp declared he obtained 66 hair out of 100 injections on himself.
"Among the 7 subjects that were enrolled for phase I, 5 reported an increase in hair numbers. Dr. Kemp, being one of the test subjects himself, reported an improvement of about 66 new hairs as a result of the 100 injections. Varying degree of hair regeneration was observed among the 5 participants who showed an improvement. Dr. Kemp's results were considered average among the 5 participants. There were volunteers who actually reported greater increase in hair numbers than Dr. Kemp. It is unknown why 2 of the 7 participants did not show any improvement. One possible explanation is the timing of hair cycling. »
What is even more inquisitive is the very evasive answer to the question: “how can we be sure that those are new born hair and not existing hair reactivated?”: "When asked about the age-old question of whether this type of cell therapy rejuvenates existing follicles or creates new ones, Dr. Kemp said it is not really their goal to understand how the new hairs are formed. It could very well be a combination of both. More in-depth studies and research are necessary before an intelligent answer can be deliberated."
The protocol will evolve according to the results observed. A few years ago, it seemed like Intercytex was going to provide mankind with the definitive solution to hair loss. They made tests on two different recipient sites: on a completely bald area of 1 cm² , and on an area still containing miniaturized hair.
This hair regeneration therapy, known as ICX-TRC, showed great promise: it was going to be cheaper, less uncomfortable and more effective than hair transplants. Results from clinical trials looked good and commercial application seemed to be only a few years away.
But recently, Intercytex has been oddly quiet about their hair loss cure. Speculation and rumors concerning the company and the product still circulate the web, but actual data is disappointingly lacking.
While we wait for new information, a recap of the story so far is in order.
Latest information, January 2010. Intercytex has been put up for sale and it seems that it stops their activities. As always, information are reduced to their simplest expression with this firm. As mentionne earlier, the feeling of blur and the abscence of actual results seem to be confirmed by the cessation of their activity.
Here is the link confirming the sale of its other business assests.
The other firm, Aderans, is not even in a clinical phase. So, this could probably mean that we are not going to see the results soon.